Allogeneic reactions of pre-activated CAR T cells on target-negative cancer cells
dc.contributor.advisor | Nagy, Lőrinc | |
dc.contributor.author | Li, Artyom | |
dc.contributor.department | DE--Természettudományi és Technológiai Kar--Biotechnológiai Intézet | |
dc.date.accessioned | 2024-12-17T08:29:02Z | |
dc.date.available | 2024-12-17T08:29:02Z | |
dc.date.created | 2024 | |
dc.description.abstract | T cells were isolated from 2 donor's PBMCs and transduced with HER2-CAR construct. The study evaluated the cytotoxic activity of HER2-CAR T cells against three cell lines: HER2-negative MDA cells and HER2-positive MDA-HER2 and MDA-HER2-231 cells. The results demonstrated significant cytotoxicity against MDA-HER2 cells, confirming the specificity of HER2-CAR T cells, while no cytotoxic effects were observed for HER2-negative MDA cells and MDA-HER2-231 cells, which had low expression of HER2 antigen. It implies that HER2-CAR T cells are unlikely to target healthy tissues with low expression of HER2. The same pattern was observed in the case of pre-activated T cells, and regardless of IL-2 and the donor of T cells. | |
dc.description.course | Biochemical Engineering | |
dc.description.degree | BSc/BA | |
dc.format.extent | 45 | |
dc.identifier.uri | https://hdl.handle.net/2437/383192 | |
dc.language.iso | en | |
dc.rights.access | Hozzáférhető a 2022 decemberi felsőoktatási törvénymódosítás értelmében. | |
dc.subject | CAR T cells | |
dc.subject | Immunotherapy | |
dc.subject | Cancer | |
dc.subject | HER2 | |
dc.subject.dspace | Biology::Immunology | |
dc.title | Allogeneic reactions of pre-activated CAR T cells on target-negative cancer cells |
Fájlok
Eredeti köteg (ORIGINAL bundle)
1 - 1 (Összesen 1)
Engedélyek köteg
1 - 1 (Összesen 1)
Nincs kép
- Név:
- license.txt
- Méret:
- 1.94 KB
- Formátum:
- Item-specific license agreed upon to submission
- Leírás: